Harbor Investment Advisory, LLC Incyte Corp Transaction History

Harbor Investment Advisory, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	BUY	$51.18 - $63.75 $204 - $255	4 New	4 $0
Q3 2022 Nov 01, 2022	SELL	$66.18 - $82.86 $132 - $165	-2 Reduced 4.76%	40 $3,000
Q1 2022 Apr 20, 2022	BUY	$66.02 - $79.71 $2,772 - $3,347	42 New	42 $3,000
Q2 2020 Jul 16, 2020	SELL	$74.18 - $108.93 $64,388 - $94,551	-868 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$63.18 - $85.97 $11,688 - $15,904	185 Added 27.09%	868 $64,000
Q4 2019 Jan 16, 2020	BUY	$73.04 - $95.72 $49,886 - $65,376	683 New	683 $60,000

642

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $17.1B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Harbor Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Harbor Investment Advisory, LLC with notifications on news.